Roche Receives EU Approval For Rheumatoid Arthritis Drug
September 08, 2014 at 02:14 AM EDT
Swiss drugmaker Roche Holding AG has gotten approval from the European Union for it drug RoACTEMRA, used to treat early rheumatoid arthritis, the company announced Monday.
